Tag: #Ajanta Pharma Ltd.

  • CESTAT Mumbai Clarifies Scope of Section 117 Customs Act in Export Documentation

    CESTAT Mumbai Clarifies Scope of Section 117 Customs Act in Export Documentation

    Date: 04.08.2025

    In a significant ruling, the Customs, Excise & Service Tax Appellate Tribunal (CESTAT), Mumbai, has set aside a penalty of β‚Ή2,00,000/- imposed on M/s Ajanta Pharma Ltd. under Section 117 of the Customs Act, 1962. The case revolved around alleged mis-declaration in Airway Bills for 43 consignments of pharmaceutical products exported between September 2018 and March 2021. ​ This decision highlights the importance of adhering to legal provisions and ensuring due process in penalty imposition. ​

    Ajanta Pharma Ltd., a prominent pharmaceutical exporter, faced allegations of mis-declaration in Airway Bills, where the goods were described as “medical apparatus” instead of their actual descriptionβ€”Erectile Dysfunction Medicines such as Kamagra Oral Jelly, Super Kamagra Tablets, and Kamagra Gold Tablets. ​ While the shipping bills, invoices, and packing lists contained accurate descriptions, the discrepancy in Airway Bills led the Customs Department to impose a penalty under Section 117 of the Customs Act, 1962. ​

    The penalty was challenged by Ajanta Pharma Ltd., arguing that the alleged contravention pertained to provisions of the Foreign Trade Policy 2015-20, not the Customs Act. ​ The company contended that no violation of the Customs Act was established, making the penalty unsustainable.

    Handy Download: